Mass-spectrometry-based proteomics has become an essential tool for the qualitative and quantitative analysis of cellular systems. The biochemical complexity and functional diversity of the ubiquitin system are well suited to proteomic studies. This review summarizes advances involving the identification of ubiquitinated proteins, the elucidation of ubiquitin-modification sites and the determination of polyubiquitin chain linkages, as well as offering a perspective on the application of emerging technologies for mechanistic and functional studies of protein ubiquitination.
. In a series of elegant experiments, Ciechanover et al. and Hershko et al. posited that the ATP-dependent modification of protein substrates by ubiquitin (which was termed APF-1 at the time) targeted them for degradation 4, 5 . This hypothesis was substantiated when Varshavsky and colleagues demonstrated a role for ubiquitin in protein turnover within cells 6, 7 . Since that time, ubiquitination has emerged as a central regulatory mechanism that controls not only protein stability, but also localization, interactions and functional activity for a vast number of protein substrates (Fig. 1) .
The hallmark of the ubiquitin system is post-translational modification of protein substrates by ubiquitin, which is a highly conserved 76-amino-acid polypeptide. The carboxy-terminal glycine residue of ubiquitin is covalently linked through an isopeptide bond to the side chain of lysine(s) within the substrate. Substrates can be modified, either by a mono-ubiquitin, multiple mono-ubiquitins (multi-ubiquitination) or a polyubiquitin chain(s) (polyubiquitination) (Fig. 1) . In addition to ubiquitin, an entire family of ubiquitin-like (Ubl) proteins has been discovered. These proteins share significant sequence homology to ubiquitin and, in many cases, form covalent post-translational modifications by similar mechanisms. However, whereas ubiquitin often acts as a degradation signal, Ubl modifications seem to exclusively modulate non-proteasomal endpoints. Among these Ubl proteins are SUMO (small ubiquitin-like modifier) 8 , ISG15 (interferon-stimulated gene of 15 kDa) 9 and NEDD8 (neural-precursor-cell-expressed and developmentally downregulated gene) 10, 11 . Due to improvements in instrument sensitivity, mass accuracy, peptide fragmentation and database searching, mass-spectrometry-based proteomics is becoming a mature platform for the systematic characterization of both the ubiquitin and Ubl systems. This review will focus on the existing and future applications of mass-spectrometry-based proteomics in such analyses. We will discuss the use of shotgun sequencing to identify protein substrates, and ubiquitin/Ubl modification sites, as well as enzymes that are involved in ubiquitination (ligases), deubiquitination (DUBs) and ubiquitin-dependent proteolysis (26S proteasome). Ongoing work in this area seeks to develop a more complete understanding of the structure and function of polyubiquitin chains, and to define the role and specificity of ubiquitin-binding proteins. As these and other mechanistic studies require carefully controlled comparisons between samples, pertinent subtractive/differential display approaches will be discussed. Finally, the focus will shift to the looming impact of stableisotope-based quantitative approaches and their unequalled potential for further elucidation of the ubiquitin system.
Shotgun sequencing by mass spectrometry as a biological assay
The term 'shotgun sequencing' -first coined by Yates and colleagues, refers to the automated identification and cataloguing of proteins directly from complex mixtures 12 . At the heart of shotgun sequencing is the acquisition of thousands of tandem mass (MS/MS) spectra. In this approach, proteins are enzymatically digested into peptides, separated via reverse-phase chromatography and analysed automatically by a mass spectrometer. As each MS/MS spectrum represents the measurement of fragment ions that are produced from a single peptide (Fig. 2a) , peptides are 'sequenced' by the correlation of each MS/MS spectrum against a sequence database using software 13, 14 . Complex samples containing hundreds of proteins can be sequenced during a single analysis. This approach can be used as a biological assay to probe specific cell states by collating lists of identified peptides (cataloguing proteomics), enumerating differences in peptide composition between samples (subtractive proteomics) or by comparing protein profiles between cell states using stable-isotope labelling (quantitative proteomics; Fig. 2b ).
When more complex mixtures (for example, cell lysates) are analysed, additional separation is required for maximal protein coverage. So far, reports identifying more than 1,000 proteins have used either gel-based separation of proteins (GeLC-MS) 15, 16 or multi-dimensional chromatography of peptides 17, 18 prior to performing tandem mass spectrometry (Fig. 2c) . Multi-dimensional chromatography -performed following enzymatic digestion -typically uses a step of strong cationexchange chromatography prior to reverse-phase separation. Two highprofile studies of the malaria parasite, Plasmodium falciparum, provide examples of how these two different approaches can be used for large-scale proteomic analyses 15, 17 . While generating an enormous amount of data, a significant amount of analysis time is required to process and analyse each sample individually. The original multi-dimensional approach -multidimensional protein identification technology (MUDPIT) -partially circumvents this problem by coupling the two chromatographic steps online with detection via mass spectrometry in an automated fashion, effectively eliminating many of the intermediate sample-handling steps 19 .
An advantage of multi-dimensional chromatography in ubiquitin analyses is that, as proteins in the sample are digested together (rather than being separated by molecular weight, as in GeLC-MS approaches), maximum sensitivity is obtained for each individual substrate. The loss of sensitivity resulting from molecular-weight separation can be partially overcome in GeLC-MS, as it is possible to load as much as 10 mg protein lysate on a preparative SDS-PAGE gel under optimized conditions.
Identification of substrates for ubiquitin and Ubl proteins
Initial contributions of mass-spectrometry-based proteomics to the study of ubiquitin and Ubl proteins have demonstrated that as many as 1,000 ubiquitinated proteins can be identified within a single experiment 18 . Typically, substrates are purified via an amino-terminal epitope tag that is fused to ubiquitin, digested using trypsin and analysed by proteome-scale shotgun sequencing. So far, this basic approach has been used to identify both ubiquitin and SUMO substrates en masse. The first reported large-scale analysis of ubiquitinated proteins using shotgun sequencing identified 1,075 candidate substrates from yeast expressing epitope-tagged ubiquitin 18 . In subsequent studies, similar approaches were used to characterize defined subsets of ubiquitinated proteins 20, 21 , as well as proteins that had been modified by SUMO [22] [23] [24] [25] [26] . These approaches have been extended into mammalian systems for both ubiquitin 27 and SUMO [28] [29] [30] [31] . In addition, a transgenic mouse expressing (His) 6 -ubiquitin has been described that may be useful for isolating ubiquitinated proteins from mammalian tissues 32 . For large-scale studies, yeast offer a distinct advantage over mammalian systems as the multiple genes encoding ubiquitin can be genetically inactivated prior to introduction of epitope-tagged ubiquitin, making it the sole form of ubiquitin within cells 33 . Non-tagging strategies for enriching targets, such as using ubiquitin-binding proteins 21, 34 , may help overcome this difficulty by avoiding the use of epitope tags completely, thereby allowing for the large-scale analysis of ubiquitinated proteins from non-transfected cells, animal tissues or possibly even clinical specimens.
Although identification of cellular substrates is optimal, several reports demonstrate that in vitro systems can be used effectively to identify targets for both ubiquitin and Ubl proteins [35] [36] [37] . In vitro systems have been particularly useful in characterizing substrates for ubiquitin ligases, such as the tumour suppressor BRCA1 (refs 38, 39) and erythrocyte spectrin 40 , and the SUMOylation of CENP-C by Ubc9 (ref. 41) .
Although cataloguing proteomics often offers insights into the breadth of ubiquitin and Ubl pathways, comparative biology requires more stringent subtractive approaches 42 . Subtractive proteomics takes advantage of the fact that a mass spectrometer is a concentration-sensitive detector. As the number of peptides identified from a given protein within a mixture is roughly proportional to its abundance, comparing the number of peptides identified for a single protein in parallel samples can be semiquantitative. For example, ubiquitinated proteins were classified as substrates of the ER-associated degradation (ERAD) pathway if they showed a 'down-up-down' profile for the number of peptides identified during analysis of wild type, npl4-1 mutant and npl4-1Ubc7/∆ double-mutant strains 20 . This profile was predicted based on observations that npl4-1 mutants displayed increased levels of ubiquitinated proteins that were reversed in the absence of the E2 Ubc7. In another example, subtractive proteomics was used to identify ubiquitin substrates, the degradation of which relied on the ubiquitin-binding protein Rpn10 (ref. 21) .
Comparisons of enriched pools of ubiquitinated proteins from wild-type and mutant cells, cells in different metabolic states or cells grown under different conditions, have the potential to globally define ligase-substrate-DUB relationships. Although subtractive approaches have proven useful, our belief is that differences between samples are best quantified using stable isotope labelling. Useful stable isotopes that are readily distinguishable by mass spectrometry include deuterium, 13 C and 15 N, which each provide a mass increment of ~1 Da per atom. Two common approaches used for the incorporation of stable isotopes are metabolic labelling [43] [44] [45] and post-harvest derivatization 46 . Both methods facilitate the comparison of proteins between two or more samples following differential labelling ( Fig. 3) . Quantification in both strategies relies on the fact that unlabelled and labelled versions of a peptide are chemically identical and co-elute during reverse-phase chromatography, as long Only two routes have proven to be successful for identifying thousands of proteins from a single sample. Both strategies use multiple steps to fractionate the original sample before mass spectrometry analysis. In one strategy, SDS-PAGE separation followed by MS/MS analysis of many gel regions (sometimes called GeLC-MS) is used. When using multiple-dimensional chromatography, protein mixtures are directly proteolysed, and the peptide mixture is separated first by strong cation-exchange chromatography. In both cases, the final step involves reverse-phase separation of peptides from multiple samples, followed by tandem mass spectrometry analysis of multiple samples. Both techniques provide the opportunity to collect hundreds of thousands of MS/MS spectra from a single sample in less than 24 h. N isotopes are used for labelling. A peptide derived from a protein that is present at a twofold higher concentration in one sample than the other is represented by a pair of peptides with peak intensities differing by twofold (Fig. 3) . As the large-scale characterization of ubiquitinated proteins is often partially obstructed by huge excesses of peptides from ubiquitin, any method that does not detect ubiquitin peptides offers a unique analytical benefit. Because the isotope-coded affinity tagging (ICAT) strategy is based on enrichment of cysteine-containing peptides -cysteine being a residue that is completely lacking within ubiquitin -the quantification of ubiquitinated proteins using ICAT offers this benefit (Fig. 3) . In any case, by adapting workflows for shotgun proteomics (Fig. 2b) , thousands of peptides and their corresponding isotopic pairs can be sequenced and quantified from a single sample.
Although mass spectrometry offers a powerful tool for identifying ubiquitin and Ubl substrates, a number of unresolved issues remain. Despite many advances, mass spectrometry data is inherently biased towards more abundant substrates. The effects of epitope tags on ubiquitin and Ubl proteins remain incompletely understood, including whether purification biases exist and whether ubiquitin pathway enzymes use tagged and wild-type ubiquitin with equal efficiency. Ongoing work seeks to determine whether ubiquitin-binding proteins or ubiquitin antibodies may work efficiently as affinity reagents, thereby lessening the need for epitope-tagged ubiquitin.
Validation of database-matched proteins as true substrates remains a major endeavour as ubiquitin/Ubl-and substrate-associated proteins can co-purify with true targets, particularly when affinity purifications are performed solely under non-denaturing conditions. Several non-massspectrometry-based approaches may be useful for validating substrates and for identifying substrates that are present in low abundance. Genetic methodologies, including two-hybrid screens and high-copy suppressor screens, have been used to identify SUMO substrates 25 . High-throughput immunoprecipitation and western blot analysis of epitope-tagged proteins -both recently used to identify direct and indirect SUMO targets 47 -may be a feasible approach for the systematic validation of substrates of ubiquitin and other Ubls that have been identified by shotgun sequencing.
In an effort to increase the stringency of ubiquitin/Ubl substrates that have been identified by shotgun sequencing, a general trend towards double-affinity purification procedures has emerged 21, 22, 24, 25 . Several groups studying both ubiquitin and SUMO have demonstrated that these approaches can be useful for identifying low-abundance substrates, while minimizing the number of false-positives. Two papers using a single-step versus a double-affinity purification provide a relevant basis for comparing and contrasting the enrichment and analytical aspects of these methods 23, 24 . Although generating largely overlapping lists, an optimized MUDPIT analysis 23 successfully identified more proteins than double-affinity purification coupled to GeLC-MS 24 . One advantage of the double-affinity approach was that it acted as independent confirmation that all identified proteins were true substrates, even in the absence of follow-up studies. Interestingly, both protocols result in some false-negatives. Despite identifying more proteins, the incidence of false-negatives following single-step purification may actually underestimate the number of modified proteins, as many proteins are ruled out as potential substrates based on their identification in the negative control sample. By contrast, stringency -that is inherent to the multistep purification -results in the loss of some true substrates prior to mass spectrometry analysis. 
Figure 3
Quantitative profiling of ubiquitinated proteins using stable isotopes. The isotope-coded affinity tag (ICAT) strategy is shown for comparing ubiquitinated proteins between wild-type cells and mutant cells lacking a ubiquitin pathway enzyme (for example, DUB, E2 or E3). In an ICAT experiment, protein is harvested from two samples and differentially labelled at cysteine residues with either a 12 C-or a 13 C-containing reagent (shown in green or blue). After labelled proteins are mixed, ubiquitinated proteins are affinity-purified and digested into peptides. The ICAT label allows for further enrichment of cysteine-containing peptides, thereby eliminating all peptides that have been derived from ubiquitin. As 12 C-and 13 C-containing peptides co-elute by reverse-phase chromatography, they can be simultaneously quantified during mass spectrometry (MS) analysis. Rapid cycling between mass spectrometry and tandem mass spectrometry (MS/MS) modes allows for the acquisition of both sequence and abundance information for isotopic peptide pairs. In this example, protein 'A' is exclusively ubiquitinated in mutant cells, whereas protein 'B' ubiquitination is increased in mutant cells. Protein 'C' is ubiquitinated equally in both samples. Other potential strategies would use similar workflows with minor modifications. Metabolic labelling (for example, SILAC) involves the incorporation of isotopes into living cells before harvest, and would not use the cysteine-enrichment step. A benefit of metabolic labelling would be quantification of non-cysteine-containing peptides, which would include most -GG signature peptides.
Characterization of enzymes regulating ubiquitin and Ubl systems
In addition to analyses that are focused on substrate identification, massspectrometry-based proteomics has been useful in characterizing many enzymatic components of the ubiquitin system. Tandem mass spectrometry has been used to identify novel members of the yeast anaphase promoting complex (APC) 48, 49 and to characterize a network of Skp-Cullin-F box (SCF) ubiquitin ligases 50, 51 . Enzymes that regulate the ubiquitination of substrates such as p53 (refs 52-54), IκB 55 , histones 56, 57 , c-Jun 58 and the epidermal growth-factor receptor 59 have also been studied. Comprehensive analyses of the intact 26S proteasome have yielded various novel proteasome-associated proteins, including both the APC and the SCF E3 ligases 60 , as well as helping to demonstrate that the Rpn11 subunit acts as a deubiquitinating enzyme for incoming proteasome substrates 61 . In a series of reports, activity-based probes, coupled with mass spectrometry, have been used to characterize known DUB enzymes, identify a novel family of DUBs and to perform expression profiling of DUBs in various cells and tissues [62] [63] [64] . The versatility of these probes was further extended to the characterization of deconjugating enzymes for SUMO, NEDD8 and ISG15 (ref. 65 ).
Identification of ubiquitin and Ub-like modification sites
Large-scale analysis of post-translational modifications, particularly protein phosphorylation, remains a fruitful area of research for mass-spectrometry-based proteomics 66, 67 . By using mass spectrometry coupled to phosphopeptide-enrichment strategies -such as immobilized metal affinity chromatography 68 , strong cation-exchange chromatography 69 or peptide immunoprecipitation 70 -thousands of modification sites have been identified. Recently, these approaches have been modified to identify ubiquitination sites. Unlike with phosphorylation, the identification of consensus ubiquitination sites based on primary sequence seems unlikely. Rather, we feel that the combination of mass spectrometry approaches with three-dimensional protein structures will be useful in identifying exposed surfaces on which protein modification is occurring at a number of similarly positioned lysines. As the number of identified ubiquitination sites increases, one related benefit may be the identification of recognition motifs for enzymes such as ligases or DUBs. As only a handful of bona fide ubiquitination sites are currently known, significant efforts are needed in this area.
A number of studies have shown that precise ubiquitination sites can be identified using mass spectrometry, by taking advantage of the fact that isopeptide-linked ubiquitin is cleaved by trypsin at the junction between Arg 74 and Gly 75, producing a -GG signature peptide (Fig. 4) 18,20,39, [71] [72] [73] . Two large-scale studies have been performed to identify ubiquitination sites from yeast 18, 20 . In more focused studies, modification sites on Gpa1 (ref. Despite these successes, the identification of ubiquitinated lysines has proven to be difficult for many proteins. Whereas site-directed mutagenesis of ubiquitinated residues in Gpa1 and TRAF1 nearly eliminated substrate Figure 4 Detecting unique diglycine (-GG) signature peptides for each polyubiquitin chain linkage. Each polyubiquitin chain conformation can be detected by monitoring a unique signature peptide containing a -GGmodified lysine residue, which has been produced by trypsin cleavage. The full amino-acid sequence of human ubiquitin is shown at the top. Ubiquitin-ubiquitin linkages correspond to isopeptide bonds formed between the carboxy-terminal glycine (blue) of one ubiquitin and the ε-amino group of a lysine residue (red) within the second. These linkages can be formed through any of seven lysine residues (Lys 6, Lys 11, Lys 27, Lys 29, Lys 33, Lys 48 and Lys 63) (red). As an example, Lys 48, Lys 63 and Lys 11 chains are depicted. Digestion of these linkages with trypsin produces peptides with distinct amino-acid sequences (see insets). Trypsin cleaves at lysine and arginine residues within both primary and branched ubiquitin molecules (see arrows in insets), but cannot cut at lysines that have been modified by isopeptide-linked ubiquitin (see underlined in insets). The resulting tryptic peptides contain a -GG-modified lysine, bearing an additional mass of 114.04 Da, which denotes the original position of the modification. Database searching algorithms can use both the missed cleavage and the -GG modification as search criteria when assigning precise sites of ubiquitination. In the case of a forked polyubiquitin chain, as demonstrated through Lys 29 and Lys 33, two -GGmodified lysines are detected on the same peptide. modification 71, 74 , in many cases, downstream function requires that only one of a subset of lysines be ubiquitinated 76, 77 . When identifying ubiquitination sites on a protein, it is common to find that each individual lysine is modified in only a fraction of the sample. This multiple lysine effect decreases the abundance of each individual -GG signature peptide. As many proteins are heterogeneously polyubiquitinated, which is indicated by ubiquitin smears that extend >100 kD on an SDS-PAGE gel, common methods such as gel-band analysis must be optimized for each individual substrate. In several cases, this problem has been overcome using multidimensional chromatography approaches coupled to mass spectrometry, in which proteins are digested in solution without SDS-PAGE separation 18, 20, 73 . Additionally, because of the missed lysine cleavage at the ubiquitin modification site, some -GG signature peptides become too large for standard analyses, and require alternate digestion strategies.
In attempts to circumvent some of these complications, several groups have sought to develop new techniques for detecting precise ubiquitination sites. The high mass accuracy of Fourier-transformed ion-cyclotron resonance mass spectrometry has been beneficial for identifying ubiquitination sites 78 . Alternate enzymes can be used to digest substrates and to generate significantly longer signature peptides (for example, STLHLVLRLRGG for GluC) 79 , which are reminiscent of the lysine modifications that are produced following tryptic digestion of several Ubl proteins (such as SUMO-2, SUMO-3 and Hub1). By contrast, if -GG signature peptides lack basic residues and are effectively too long for analysis, the use of multiple enzymes may be beneficial 73 . One disadvantage of using trypsin is that it forms identical -GG signature peptides for ubiquitin, as well as the Ubl proteins NEDD8 and ISG15. Alternate enzymes that produce slightly larger signatures easily differentiate between the three. These alternate or multiple enzyme strategies are particularly effective when focusing on a single protein in experiments in which the approach can be directly tailored based on the amino-acid sequence of the substrate.
Another approach involves amino-terminal labelling of peptides either by sulphonation 80 or modification by fluorous affinity tags 81 . The benefit of such a post-digest labelling approach is that, as -GG signature peptides effectively have two amino termini, and typical tryptic peptides only one, enrichment of peptides that have multiple labels can concentrate -GG signature peptides 81 . Additionally, strategies that have been developed for large-scale phosphopeptide identification, such as peptide immunoprecipitation 70 or ion-exchange chromatography 69 , may also be useful for capturing -GG signature peptides. Although further work is needed to test the utility of newly developed methods in the large-scale identification of ubiquitination sites from in vivo substrates, work involving phosphopeptides indicates that prefractionation of -GG signature peptides will be a key component of any successful strategy.
Defining the structure of polyubiquitin chains
The formation of a polyubiquitin chain provides an opportunity for increased regulatory complexity within many ubiquitin-dependent processes 82 ( Fig. 1) . Much of the current understanding of the function and frequency of various polyubiquitin linkages is derived either from experiments performed using lysine-to-arginine mutant forms of ubiquitin 33, 83, 84 or studies performed with synthetic polyubiquitin chains [85] [86] [87] . Additional reports indicate that antibodies with preferences for and/or against specific forms of ubiquitin may be used to differentiate between mono-ubiquitin and polyubiquitin in samples [88] [89] [90] . The indirect nature of these molecular approaches relies on a number of assumptions.
Although preventing the formation of certain ubiquitin-ubiquitin linkages, substitution of highly conserved lysines within the ubiquitin sequence could also have uncharacterized effects on protein-protein interactions, enzyme activities or polyubiquitin chain formation within a complex system. Synthetic chains are a proven biochemical tool, but may not be representative of all substrates carrying a similar modification. Despite the proven utility of these molecular strategies, there remains a need for a direct, quantitative method to analyse polyubiquitin chain composition. As trypsin digestion of a polyubiquitin chain produces unique -GG signature peptides for each possible linkage, analysis of these peptides can allow direct measurement of linkage types and frequencies (Fig. 4) .
Large-scale shotgun sequencing studies have identified -GG signature peptides from the various types of polyubiquitin chains. For example, in yeast, it was shown that all seven lysines in ubiquitin can participate in polyubiquitin chain formation in vivo 18 . Furthermore, in the same study, a branched ubiquitin peptide was also identified in which a single ubiquitin was simultaneously modified at two adjacent residues (Lys 29 and Lys 33). These observations indicate that chain formation through alternative lysines within ubiquitin may provide new levels of regulatory complexity. Analysis of ubiquitinated Met 4 purified from yeast showed it to be modified by Lys 48-linked chains, despite the fact that the substrate was stable and not being targeted for degradation 73 . Subsequent reports have also used mass spectrometry to examine polyubiquitin linkages formed during in vitro reactions. In two such examples, the yeast Ufd2 ligase complex was shown to synthesize both Lys 48 and Lys 63 chains 91 , whereas the BRCA1-BARD1 heterodimer generated Lys 6 linkages 92, 93 . In all of these studies that use either shotgun sequencing or more focused MS/MS approaches to identify the presence of specific polyubiquitin chain linkages, caution should be used. Due to peptidespecific chromatographic properties, as is the case with the diminutive Lys 29 branched peptide, or mass spectrometry insensitivity, as with the Lys 11 branched peptide from yeast, absence of evidence should not necessarily be construed as evidence of absence.
Many laboratories are involved in understanding the biological consequences of protein polyubiquitination through non-canonical ubiquitin-ubiquitin linkages. Whereas Lys 48-and Lys 63-linked chains have been tied to many effects within cells, little is known about chains that are formed through Lys 6, Lys 11, Lys 29 and others. Recently, mass spectrometry was used to demonstrate the effect of biotinylation and/or mutation of Lys 6 in processes such as ubiquitin attachment and proteasomal degradation 94 . Another group purified and identified linkagespecific binding proteins associated with Lys 29-linked chains, including two proteins from the ubiquitin pathway -Ubp14/isopeptidase T and Ufd3 (ref. 95 ). The extension of these studies to other chain linkages should further elucidate the mechanisms through which polyubiquitin chains dictate biological functions.
Mass-spectrometry-based proteomics has begun to make progress towards a direct, quantitative method for analysing polyubiquitin chains (D.S.K. and S.P.G., manuscript in preparation). The absolute quantification (AQUA) method 96 may be useful in revalidating many basic tenets within the ubiquitin field, including discoveries made using mutant ubiquitin in genetic and biochemical analyses. For example, the in vivo role of specific polyubiquitin linkages, including the highly abundant Lys 48 linkage, in chain formation, processing and substrate degradation is not fully understood. The modification of substrates by multiple monoubiquitins has been reported to have distinct effects on the localization of proteins such as p53 (ref. 97 ) and receptor tyrosine kinases 90 , whereas oligo-ubiquitination (short polyubiquitin chains -for example, Ub3) was recently shown to be a regulated intermediate in protein degradation 98 . In both cases, as AQUA would facilitate measurements of frequency for mono-ubiquitination and various polyubiquitin chain linkages, it may be useful in testing the generality of these observations and the possibility of extending them into a broader biological context.
Emerging concepts and concluding remarks
The 2004 Nobel Prize in chemistry was awarded to Avram Hershko, Aaron Ciechanover and Irwin Rose in recognition of the central importance of ubiquitin in regulating protein degradation. Since that initial discovery, the ubiquitin system has matured from a biochemical explanation for how proteins are degraded to a ubiquitous regulatory network that is deserving of its name. Nevertheless, a number of fundamental questions remain as to the biochemical mechanisms and functional consequences of ubiquitination. Simple questions, such as which ligases are responsible for targeting individual substrates for degradation, are already being addressed using shotgun sequencing methods and stable-isotope-based quantification. Subsequently, it will be important to validate recent advances in our understanding of ubiquitin receptors/ubiquitin-binding factors 98, 99 in the format of large-scale experiments that examine bulk substrate turnover. In the case of proteasome-independent signalling by ubiquitin, the continued identification of substrate modification sites and polyubiquitin chain linkages will be necessary to understand mechanistic specificity. In all cases, the coupling of mass-spectrometry-based approaches with genetic mutants 33 , small-molecule perturbants 100 or technologies such as small interfering RNA, has the potential to define both substrate-specific and global aspects of protein ubiquitination.
Arguably, the largest remaining void in the ubiquitin research field is our understanding of the structure and function of polyubiquitin chains. As was the case with ubiquitin function, the mechanisms of polyubiquitin chain formation are more complex than were originally imagined. Circumstantial evidence points towards the possibility that a proportion of polyubiquitin chains may be synthesized with mixed linkages, although neither the frequency nor the relevance of such structures has been sufficiently addressed. Specifically, it is known that forked polyubiquitin chains can form within cells through adjacent lysines within ubiquitin (for example, Lys 29-33) 18 . Does polyubiquitin chain forking occur through non-adjacent lysines within ubiquitin, and, if so, how abundant is it within cells? Furthermore, are these heterogeneous chains or forked structures esoteric, or are they indicative of an additional level of regulatory complexity that is reminiscent of complex carbohydrate signalling? With regards to Lys 48-linked chains, given their defined role in proteolysis, how can the high relative abundance of these chains within living cells be explained? Currently, it is only possible to speculate at reasons, such as the inherent stability of some Lys 48 chains, the presence of linkage specificity factors regulating assembly or disassembly of non-Lys 48 linkages, and/or preferences of E2 enzymes for Lys 48 synthesis. Direct, quantitative analysis of polyubiquitin chains in vitro and in vivo has the potential to address these questions.
Mass-spectrometry-based proteomics, and particularly the development of stable-isotope-based quantification, has helped transition many questions within the ubiquitin field from the arena of theory and speculation into a landscape in which they may be addressed by hypothesisdriven experimentation. Proteomic experiments will allow researchers to directly address numerous biochemical and functional aspects of the ubiquitin system that cannot be addressed by existing molecular techniques. Only through the union of these two fields can the full biological scope of protein ubiquitination be revealed.
